EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Cardiovascular remodelling in patients with pre-dialysis chronic kidney disease and renal transplant recipients

Ramajana Temimović, Senija Rašić, Alen Džubur

Medicinski Glasnik · 2019

DOI: 10.17392/1009-19 ↗
AbstractBibliografische Angaben

Abstract

<p><strong>Aim</strong> <br />To evaluate the relationship between cardiovascular remodelling and glomerular filtration rate (eGFR) in pre-dialysis chronic kidney disease (CKD) patients without cardiovascular diseases (CVD) and in renal transplant recipients (RTR). <br /><strong>Methods<br /></strong> The cross-sectional study included 83 patients with eGFR&lt;60 mL/min/1.73m 2 (45 with CKD 3 stage and 38 with CKD 4 stage). Thirty six RTR had eGFR 67.8 (57.3-73.7) mL/ min/1.73m 2 and control group consisted of 44 patients with eGFR&gt;60 mL/min/1.73m 2. All patients were evaluated by echocardiography and X-ray. <br /><strong>Results<br /></strong> Left ventricular hypertrophy (LVH) was present in 74.7% CKD patients, most frequently in CKD 4 stage and in RTR. Calcifications of abdominal aorta (CAA) were present in 87% CKD 4, 60% RTR and in 44% CKD 3 patients. Calcifications of the mitral valve were found in 34.2% CKD 4, 25.0% RTR and in 6.7% CKD 3 stage patients. Aortic valve calcifications were most frequently present in CKD 4 stage (26.3%). The LV mass index negatively correlated with eGFR (p&lt;0.001), and positively with parathyroid hormone (p&lt;0.001), phosphorus (p=0.043), age (p&lt;0.001) and diabetes (p=0.043). In multivariate regression analysis the risk factor for calcifications of the mitral and aortic valve, as well as for CAA was the decline in eGFR (p&lt;0.001). <br /><strong>Conclusion<br /></strong> Renal transplant recipients have a higher incidence of CV remodelling than patients with CKD 3 and less than patients with CKD 4 stage, indicating incomplete regression of CV calcifications and LVH after kidney transplantation. A decrease of renal function represents a significant risk factor for valvular and vascular calcifications occurrence in CKD patients.</p>

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →